Matthew P. Young's most recent trade in CytomX Therapeutics Inc was a trade of 38,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 15, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
CytomX Therapeutics Inc | Matthew P. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
CytomX Therapeutics Inc | Matthew P. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
CytomX Therapeutics Inc | Matthew P. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
CytomX Therapeutics Inc | Matthew P. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
CytomX Therapeutics Inc | Matthew P. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |